These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2750514)

  • 1. Prognostication including DNA analysis in osteosarcoma.
    Bauer HC; Kreicbergs A; Silfverswärd C
    Acta Orthop Scand; 1989 Jun; 60(3):353-60. PubMed ID: 2750514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA cytometry of osteosarcoma.
    Bauer HC
    Acta Orthop Scand Suppl; 1988; 228():1-39. PubMed ID: 3063059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA analysis in the differential diagnosis of osteosarcoma.
    Bauer HC; Kreicbergs A; Silfverswärd C; Tribukait B
    Cancer; 1988 Jun; 61(12):2532-40. PubMed ID: 3163257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA analysis in the differential diagnosis of osteosarcoma.
    Bauer HC; Kreicbergs A; Silfverswärd C; Tribukait B
    Cancer; 1988 Apr; 61(7):1430-6. PubMed ID: 3422833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
    Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
    Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
    Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
    Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
    BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmetastasis survival in high-grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients.
    Kim W; Han I; Lee JS; Cho HS; Park JW; Kim HS
    J Surg Oncol; 2018 May; 117(6):1223-1231. PubMed ID: 29409122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma.
    Kong CB; Song WS; Cho WH; Oh JM; Jeon DG
    Clin Orthop Relat Res; 2012 May; 470(5):1482-90. PubMed ID: 22009712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute.
    Staals EL; Bacchini P; Bertoni F
    Cancer; 2008 Apr; 112(7):1592-9. PubMed ID: 18300258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma of the pelvis: outcome analysis of surgical treatment.
    Fuchs B; Hoekzema N; Larson DR; Inwards CY; Sim FH
    Clin Orthop Relat Res; 2009 Feb; 467(2):510-8. PubMed ID: 18855090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L; Deng S; Zhang F; Liang Y; Huang Z
    World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
    Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
    Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteosarcoma: the COSS experience.
    Bielack S; Jürgens H; Jundt G; Kevric M; Kühne T; Reichardt P; Zoubek A; Werner M; Winkelmann W; Kotz R
    Cancer Treat Res; 2009; 152():289-308. PubMed ID: 20213397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    J Surg Oncol; 2008 Apr; 97(5):456-61. PubMed ID: 18270971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
    Xie L; Guo W; Li Y; Ji T; Sun X
    J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Pathological Fractures on the Prognosis of Primary Malignant Bone Sarcoma in Children and Adults: A Single-Center Retrospective Study of 205 Patients.
    Schlegel M; Zeumer M; Prodinger PM; Woertler K; Steinborn M; von Eisenhart-Rothe R; Burdach S; Rechl H; von Luettichau I
    Oncology; 2018; 94(6):354-362. PubMed ID: 29656296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multivariate analysis for prognostic factors among 43 patients with osteosarcoma].
    Zhang B; Pang QJ; Zhang HJ; Yuan Y
    Zhongguo Gu Shang; 2011 Dec; 24(12):982-6. PubMed ID: 22276503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.